Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Splicing factor ESS-2 homolog (ESS2) is a peripheral component of the spliceosome found in humans and other eukaryotes, encoded by a gene in the DiGeorge syndrome 22q11.2 deletion region. ESS2 is critical for the regulation of pre-mRNA splicing with specific roles in the transition and assembly of C and C* spliceosome complexes. In addition to its splicing function, ESS2 acts as a transcriptional coregulator, influencing the expression of genes involved in cell differentiation, proliferation, neuronal development, and immune responses. ESS2 has direct interactions with key splicing and transcriptional regulatory proteins, including nuclear hormone receptors. Loss of ESS2 function leads to early embryonic lethality in mice, and dysregulation is implicated in cancer, neurodevelopmental, and autoimmune disorders. The molecular details of ESS2's dual roles in splicing and transcriptional regulation are still under investigation. No drugs are currently known to directly target ESS2, but its central regulatory role makes it a candidate biomarker and a potential future therapeutic target in diseases involving disrupted splicing or transcription regulation[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Splicing factor ESS-2 homolog (ESS2).